Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Reflect ScientificRSCF -8.89% Price-to-Tangible-Book is 1.71 as of Sep. 14, 2026. The stock has 4 warning signs investors should review. Among 703 Medical Devices & Instruments companies, Reflect Scientific ranks better than 55.05% on this metric.
The historical rank and industry rank for Reflect Scientific's Price-to-Tangible-Book or its related term are showing as below:
RSCF'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.88 Med: 6 Max: 35.71
Current: 2.05
During the past 13 years, Reflect Scientific's highest Price to Tangible Book Ratio was 35.71. The lowest was 1.88. And the median was 6.00.
RSCF's Price-to-Tangible-Book is ranked better than 55.05% of 703
companies
in the Medical Devices & Instruments industry
Industry Median: 2.61
vs RSCF: 2.05
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Reflect Scientific Price-to-Tangible-Book Related Terms
Reflect Scientific Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Reflect Scientific's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RSCF vs NXGL, ECIA, YBGJ: Price-to-Tangible-Book Comparison
For the Medical Instruments & Supplies subindustry, Reflect Scientific's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reflect Scientific Price-to-Tangible-Book vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Reflect Scientific's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Reflect Scientific (RSCF) has a Price-to-Tangible-Book of 1.71 as of Sep. 14, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Reflect Scientific and its competitors. According to the industry distribution chart, Reflect Scientific ranks #316 out of 703 companies in the Medical Devices & Instruments industry, placing it in the top 45%.
Is Reflect Scientific's Price-to-Tangible-Book too high?
Reflect Scientific's current Price-to-Tangible-Book is 1.71. The Medical Devices & Instruments industry median Price-to-Tangible-Book is 2.61. Reflect Scientific's value of 1.71 is 34.5% below this industry median. Based on the distribution chart, Reflect Scientific ranks #316 out of 703 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Reflect Scientific's Price-to-Tangible-Book compare to NXGL and ECIA?
According to the Medical Devices & Instruments industry distribution chart, Reflect Scientific ranks #316 out of 703 companies for Price-to-Tangible-Book. This puts Reflect Scientific in the upper half of its industry. The industry median Price-to-Tangible-Book is 2.61. Reflect Scientific's value of 1.71 is 34.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Medical Devices & Instruments company?
The median Price-to-Tangible-Book among Medical Devices & Instruments companies is 2.61, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Reflect Scientific's current Price-to-Tangible-Book of 1.71 is 34.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Reflect Scientific and its competitors. For the Medical Devices & Instruments industry, the median Price-to-Tangible-Book is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reflect Scientific's current Price-to-Tangible-Book is 1.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reflect Scientific stock overvalued right now?
Reflect Scientific (RSCF) has a current Price-to-Tangible-Book of 1.71. The current Price-to-Tangible-Book is 1.71 and 34.5% below the Medical Devices & Instruments industry median of 2.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current Price-to-Tangible-Book is 1.71 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RSCF has been successfully added to your 
